SHYFT Analytics

11 articles about SHYFT Analytics

• 

  BioSpace Movers and Shakers: March 1

  3/1/2019

  Pharma and biotech companies make changes to leadership roles, with new hires at Agios, Notable, Rapamycin, Confo, AVEO and more.

• SHYFT Expands Real-World Evidence Solutions Empowering Life Sciences to Make Better Value-Based Decisions

  2/28/2019

  Leader in commercial and real-world data analytics adds services, capabilities, and expertise to unlock the value of RWE across the industry

• 

  With New HQ, Boston’s Medidata Expects to Hire 600-800 Over Next 5 Years

  2/15/2019

  “This is Medidata’s first office in Boston, and the company is excited for the opportunity over the next several years to tap into the amazing life sciences and technology skills that Boston can offer,” said Medidata’s chief people officer.
• 

  Novartis to Launch Innovation Labs Across the Globe, Including Silicon Valley

  10/9/2018

  To spur innovation and bolster ties with tech giants, Swiss pharma giant Novartis plans to set up innovation labs across the globe to partner with these companies to spur the development of new therapies.

• Novartis Partners with SHYFT to Support its Digital Transformation

  7/24/2018

  Agreement accelerates Novartis’ ability to use data and digital to transform commercial models, ensuring more meaningful interactions with healthcare providers

• Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics

  6/12/2018

  Leading the digital transformation of life sciences with artificial intelligence and advanced analytics.

• SHYFT Debuts New Lumen UI, its Latest Analytics and Data Visualization Platform

  4/30/2018

  SHYFT Analytics announced the launch of Lumen.

• SHYFT Announces Promotion of Priya Sapra to COO

  1/16/2018

  Priya is part of SHYFT's executive team and oversees Product Innovation for SHYFT's award winning platform.

• Six New Companies Select SHYFT to Maximize Launch Success of Specialty and Rare Disease Brands

  10/25/2017

  SHYFT Analytics today announced that in the last quarter, six biopharma companies have chosen to launch their new therapies using the SHYFT Platform.

• Pfizer's Former Head Of Real World Data And Analytics, Marc Berger, To Lead SHYFT Analytics Product Advisory Board

  9/12/2017

• SHYFT Analytics Announces Strategic Investment From Optum

  3/29/2017